EPISODE · May 18, 2026 · 26 MIN
Irina Turchin, MD, FRCPC, DABD / Hélène Veillette, MD, FRCPC - On the Case: Practical Insights to Individualize Biologic Treatment in Moderate-to-Severe Hidradenitis Suppurativa
from PeerVoice Clinical Pharmacology Video · host PeerVoice
Irina Turchin, MD, FRCPC, DABD / Hélène Veillette, MD, FRCPC - On the Case: Practical Insights to Individualize Biologic Treatment in Moderate-to-Severe Hidradenitis Suppurativa
Embed this episode
What this episode covers
For the complete activity, including supporting material, please visit https://www.peervoice.com/ACF860. Presented by Irina Turchin, MD, FRCPC, DABD and Hélène Veillette, MD, FRCPC. Learning Objectives: Review the available biologics for the management of hidradenitis suppurativa (HS); Discuss the clinical profiles of the available biologics in patients with HS; Evaluate the clinical factors that may guide treatment selection among the available biologics in patients with HS.
Ready to play
Irina Turchin, MD, FRCPC, DABD / Hélène Veillette, MD, FRCPC - On the Case: Practical Insights to Individualize Biologic Treatment in Moderate-to-Severe Hidradenitis Suppurativa
No transcript for this episode yet
Similar Episodes
No similar episodes found.